Gilda Lemos

Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)

Francisco Hernández‐Bernal, Maria C. Ricardo-Cobas, Yenima Martín‐Bauta et al. · EClinicalMedicine · 2022 · 69 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen

Miladys Limonta‐Fernández, Glay Chinea-Santiago, Alejandro Miguel Martín-Dunn et al. · New Biotechnology · 2022 · 57 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Dual infection with hepatitis A and E viruses in outbreaks and in sporadic clinical cases: Cuba 1998–2003

Licel de los Ángeles Rodríguez Lay, Ariel Quintana, María Caridad Montalvo Villalba et al. · Journal of Medical Virology · 2008 · 49 citations

Veterinary Medicine, Infectious Diseases, Microbiology +12

Diagnosis of Dengue Virus Infection by the Visual and Simple AuBioDOT Immunoglobulin M Capture System

Susana Vázquez, Gilda Lemos, Maritza Pupo et al. · Clinical and Vaccine Immunology · 2003 · 25 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice

Laura Lazo, Mónica Béquet‐Romero, Gilda Lemos et al. · Vaccine · 2022 · 21 citations · Full text

Life Sciences, Immunology, Microbiology +16